Emerging pharmacotherapies for obesity: A systematic review US$ 20.03 Min. order: 1 piece ★★★★★ 4.3 (243 reviews) Sold : Login>>
Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports US$ 24.91 Min. order: 1 piece ★★★★★ 4.4 (158 reviews) Sold : Login>>
The evolving landscape of obesity pharmacotherapy US$ 24.38 Min. order: 1 piece ★★★★★ 4.0 (215 reviews) Sold : Login>>
Updates in Medicine | Mazdutide (GLP-1/Glucagon Agonist) Cuts Weight by 14% in Obesity Trial Original Article in Bio 🔗 📊 GLORY-1 Phase 3 Trial (China, N=610) US$ 29.19 Min. order: 1 piece ★★★★★ 4.6 (53 reviews) Sold : Login>>
Mazdutide and Tirzepatide: How These Dual-Pathway Weight-Loss Drugs Really Compare US$ 21.48 Min. order: 1 piece ★★★★★ 5.0 (45 reviews) Sold : Login>>
Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review US$ 29.10 Min. order: 1 piece ★★★★★ 4.3 (56 reviews) Sold : Login>>